Skip to content

Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome

Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04535973
Enrollment
40
Registered
2020-09-02
Start date
2019-11-15
Completion date
2020-06-15
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

17β-Estradiol, Burning Mouth Syndrome, Dehydroepiandrosterone, Hormone Disturbance, Progesterone, Quality of Life

Keywords

burning mouth syndrome, hormonal status, quality of life

Brief summary

The aim of this study was to determine the level of salivary estradiol, progesterone and dehydroepiandrosterone in female postmenopausal women with and without burning mouth syndrome. In all participants the quantity of unstimulated and stimulated saliva would be determined and they would fulfill self-perceived quality of life questionnaire Oral Health Impact Profile-14 (OHIP-14). Intensity of burning symptoms would be determined on visual-analogue scale grading 0-10. All data would be compared between study and control group.

Interventions

DIAGNOSTIC_TESTunstimulated saliva sample for hormone analysis

hormone levels will be determined in frozen samples of unstimulated saliva

OTHERquality of life questionnaire

all participants will fill out self-perceived quality of life questionnaire

Sponsors

University of Zagreb
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
51 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* postmenopausal women with burning mouth syndrome

Exclusion criteria

* women with burning mouth syndrome who are not in menopause

Design outcomes

Primary

MeasureTime frameDescription
to evaluate the levels of salivary hormoneNovember 2019-June 2020levels of salivary 17β-Estradiol, progesterone and DHEA were determined in study and control group

Secondary

MeasureTime frameDescription
to evaluate quality of life and correlate it with levels of salivary hormones and intensity of symptomsNovember 2019-June 2020quality of life was evaluated with self-perceived questionnaire OHIP-14

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026